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Lip is a membrane-bound lipoprotein and a core component
of the type VI secretion system found in Gram-negative
bacteria. The structure of a Lip construct (residues 29–176)
from Serratia marcescens (SmLip) has been determined at
1.92 A ˚ resolution. Experimental phases were derived using
a single-wavelength anomalous dispersion approach on a
sample cocrystallized with iodide. The membrane localization
of the native protein was conﬁrmed. The structure is that
of the globular domain lacking only the lipoprotein signal
peptide and the lipidated N-terminus of the mature protein.
The protein foldis dominated byan eight-stranded  -sandwich
and identiﬁes SmLip as a new member of the transthyretin
family of proteins. Transthyretin and the only other member
of the family fold, 5-hydroxyisourate hydrolase, form homo-
tetramers important for their function. The asymmetric unit
of SmLip is a tetramer with 222 symmetry, but the assembly
is distinct from that previously noted for the transthyretin
protein family. However, structural comparisons and bacterial
two-hybrid data suggest that the SmLip tetramer is not
relevant to its role as a core component of the type VI
secretion system, but rather reﬂects a propensity for SmLip
to participate in protein–protein interactions. A relatively low
level of sequence conservation amongst Lip homologues is
noted and is restricted to parts of the structure that might be
involved in interactions with physiological partners.
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1. Introduction
Protein secretion systems are critical to the virulence and host-
interaction processes of Gram-negative pathogens. Different
bacterial species possess different combinations of one or
more specialized proteinaceous machines that secrete toxins,
adhesins, hydrolytic enzymes and proteins able to manipulate
eukaryotic signalling pathways (Gerlach & Hensel, 2007;
Holland, 2010). The most recently discovered system, the type
VI secretion system (T6SS), is present in many Gram-negative
bacteria and is implicated in virulence in important human
pathogens including Pseudomonas aeruginosa (Cascales, 2008;
Filloux et al., 2008; Jani & Cotter, 2010). It has also been
shown to contribute to the virulence of economically signiﬁ-
cant animal and plant pathogens (Liu et al., 2008; Blondel et
al., 2010; Sarris et al., 2010). Some T6SSs appear to target other
bacterial cells instead of, or in addition to, eukaryotic cells
(Hood et al., 2010; MacIntyre et al.,2010;Murdoch et al.,2011).
This suggests that T6SSs may contribute to allowing pathogens
to proliferate in polymicrobial infection sites and/or to persist
in different environmental reservoirs (Schwarz et al., 2010;
Murdoch et al., 2011). Serratia marcescens is an opportunisticpathogen, a signiﬁcant cause of hospital-acquired infections
and an important reservoir of antibiotic-resistance determi-
nants in the clinical environment (Hejazi & Falkiner, 1997).
It is also a tractable model organism in which to dissect the
structure–function relationships in the T6SS (Murdoch et al.,
2011).
Studies of the T6SS have started to reveal information
on the components and the biological role of this recently
discovered system (Cascales, 2008; Filloux et al., 2008;
Pukatzki et al., 2009; Bo ¨nemann et al., 2010). T6SSs are large
multiprotein complexes encoded on variable gene clusters
characterized by the presence of genes encoding 13 ‘core’
components. These are thought to form the basic secretion
apparatus, which is coupled with ‘accessory’ components that
are conserved across many or only a few systems. Key core
components include the putative extracellular Hcp/VgrG
assembly, which is thought to form a cell-puncturing device
similar to that of bacteriophage tail structures (Pukatzki et al.,
2009). There are a number of predicted cytoplasmic proteins
(e.g. an ATPase called ClpV) and several inner membrane
proteins (e.g. IcmFand IcmH). Additionally, and the subject of
this work, the only outer membrane component reported to
date is a periplasmic-facing outer membrane lipoprotein (Lip;
Aschtgen et al., 2008).
Genetic studies indicate that in S. marcescens this lipopro-
tein (SmLip) makes an essential contribution to the basic
function of the T6SS and to T6SS-dependent antibacterial
killing activity (Murdoch et al., 2011). We now report the high-
resolution structure of SmLip determined following phase
determination using single-wavelength anomalous dispersion
(SAD) measurements based on the scattering properties of
iodide ions. The localization of the protein in S. marcescens
itself and bacterial two-hybrid data are reported to investigate
the propensity for self-association. The structure reveals a
remarkable similarity to transthyretin, a vertebrate hormone-
distribution protein, and comparisons suggest which parts of
SmLip may be involved in protein–protein interactions with
partner components of the T6SS.
2. Methods
2.1. Protein expression and purification
The S. marcescens lip gene (SMA2252; Murdoch et al.,
2011) encoding amino-acid residues 30–176 was ampliﬁed
from genomic DNA (strain Db10) using the forward primer
50-catatgGCCAAAAGCGTGCCGTCGCGTTACAG-30 and
the reverse primer 50-ggatccTCAGTCGACCTTTTTTACG-
GGGCGCAGGC-30 (the lower-case sequences correspond to
the NdeI/BamHI restriction sites used for cloning). The PCR
product was ligated into PCR-BluntII-TOPO using the Zero
Blunt TOPO Cloning Kit (Invitrogen) and then cloned into
a pET15b (Novagen) cloning vector modiﬁed to encode a
tobacco etch virus (TEV) protease cleavage site in place of the
thrombin protease cleavage site. The construct was veriﬁed
by DNA sequencing (DNA Sequencing Unit, University of
Dundee).
The recombinant protein was produced in Escherichia coli
BL21 (DE3) pLysS cells (Stratagene). Cultures were grown
for 3 h at 310 K in auto-induction medium (Studier, 2005)
supplemented with 50 mgl
 1 carbenicillin before overnight
growth at 295 K. Cells were harvested by centrifugation
(3500g at 277 K for 30 min). The cell pellet was resuspended
in buffer A (25 mM Tris–HCl pH 7.5, 500 mM NaCl, 20 mM
imidazole pH 8.5) supplemented with an EDTA-free Protease
Inhibitor Cocktail Tablet (Roche) and 0.2 mg DNase I
(Sigma–Aldrich). Cells were lysed using a continuous-ﬂow
cell disrupter (Constant Systems) at 207 MPa and cell debris
was removed following centrifugation (40 000g at 277 K for
30 min). SmLip was puriﬁed using nickel-afﬁnity chromato-
graphy with a 5 ml HisTrap HP column (GE Healthcare) pre-
charged with Ni
2+. A step gradient of 5% buffer B (25 mM
Tris–HCl pH 7.5, 500 mM NaCl, 500 mM imidazole) was used
to remove histidine-rich proteins. A linear concentration
gradient of imidazole from 5 to 50% buffer B was applied to
elute the product, which was then dialyzed against buffer C
(25 mM Tris–HCl, 250 mM NaCl pH 7.5) at 277 K overnight
in the presence of His-tagged TEV protease. The resulting
mixture was applied onto the HisTrap column, which bound
the cleaved His tag, TEV protease and uncleaved SmLip. The
SmLip sample from which the His tag had been cleaved was
present in the ﬂowthrough. Fractions were analyzed using
SDS–PAGE and those containing SmLip were pooled. The
protein was further puriﬁed by size-exclusion chromatography
using a Superdex 75 26/60 column (GE Healthcare) equili-
brated with buffer C on an A ¨ KTApuriﬁer (GE Healthcare).
The columnhadpreviouslybeencalibratedwiththemolecular-
weight standards blue dextran (>2000 kDa), thyroglobulin
(669 kDa), ferritin (440 kDa), aldolase (158 kDa), conalbumin
(75 kDa),ovalbumin(43 kDa),carbonicanhydrase(29.5 kDa),
ribonuclease A (13.7 kDa) and aprotinin (6.5 kDa) (GE
Healthcare; data not shown). The protein eluted as one peak
of approximate mass 17 kDa, corresponding to a monomer.
Fractions containing the protein were pooled and concen-
trated to 10 mg ml
 1 using Amicon Ultra devices (Millipore)
for subsequent use. The purity of the protein was conﬁrmed by
SDS–PAGE and mass spectrometry (Fingerprint Proteomics
Facility, University of Dundee). A theoretical extinction co-
efﬁcient of 16 960 M
 1 cm
 1 at 280 nm was used to estimate
the protein concentration (ProtParam; Gasteiger et al., 2005);
the theoretical mass of one subunit was estimated as 16.1 kDa
with a calculated isoelectric point of 5.4. The puriﬁed protein
sample was stored at 277 K until further use.
2.2. Crystallization, data collection and structure
determination
Initial crystallization screens were carried out at 293 K by
the sitting-drop vapour-diffusion method in 96-well plates.
This was achieved using a Phoenix liquid-handling system
(Rigaku, Art Robbins Instruments) and the commercially
available PEG (Qiagen) and JCSG+ (Molecular Dimensions)
screens. Crystallization occurred in two conditions, which were
further optimized using the hanging-drop vapour-diffusion
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10 mg ml
 1 in 25 mM Tris–HCl pH 7.5, 250 mM NaCl and 1 ml
reservoir solution. The two conditions involved reservoirs
consisting of 20% polyethylene glycol 3350, 200 mM KI and
of 15% polyethylene glycol 3350, 200 mM NaCl. Monoclinic
blocks with minimum dimensions of approximately 0.3 mm
grew over 2 d and the addition of glycerol to 10% proved to be
a suitable cryoprotectant.
Crystals from the iodide-containing condition were char-
acterized ﬁrst and data set I was measured in-house using
a Rigaku MicroMax-007 rotating-anode X-ray generator
(Cu K ,  = 1.541 A ˚ ) coupled to an R-AXIS IV
++ image-plate
detector. A crystal from the second condition was stored in
liquid N2 and subsequently used to measure a high-resolution
data set (data set II) on beamline ID29 at the European
Synchrotron Radiation Facility (ESRF; Grenoble, France)
using an ADSC Q315R detector. All data were indexed and
integrated using XDS (Kabsch, 2010) and scaled using
SCALA (Evans, 2006) from the CCP4 program suite (Winn et
al., 2011).
Data set I was used to solve the structure by SAD methods
targeting the iodides present in the crystallization conditions
and to acquire a fairly complete model. The sites of potential
anomalous scattering ions or atoms were identiﬁed using
PHENIX (Adams et al., 2010) and experimental phases were
calculated using Phaser (McCoy et al., 2007). Density modiﬁ-
cation was carried out using histogram matching, averaging on
the basis of noncrystallographic symmetry (NCS), and model
building was carried out using RESOLVE (Terwilliger, 2003).
NCS restraints were employed in the initial reﬁnement
calculations, which were performed using REFMAC5( M u r -
shudov et al., 2011). Inspection of the model and the ﬁt to
electron-density and difference density maps was carried out
in Coot (Emsley et al., 2010). The analysis then switched to
the high-resolution synchrotron data set II when it became
available and this was used to complete the reﬁnement.
MolProbity (Chen et al., 2010) was used to investigate model
geometry in combination with the validation tools provided in
Coot. Analyses of surface areas and interactions were made
using the PISA (Krissinel & Henrick, 2007) web service and
secondary-structure analysis was performed using DSSP
(Kabsch & Sander, 1983). Crystallographic statistics are
summarized in Table 1.
2.3. Bacterial two-hybrid analyses
For generation of the plasmid pSC072, the gene fragment
encoding SmLip amino acids 27–176 was PCR-ampliﬁed using
primers 50-TATAgcatgcGTAAAGAGGAGGCTGCATGTC-
TTCCGCCAAAAGC-30 and 50-TATAtctagaGAGTCGAC-
CTTTTTTACGGGGC-30 and cloned into the vector pUT18
(Karimova et al., 2001) using SphI and XbaI restriction sites.
The restriction sites are shown in lower case. For generation of
another plasmid, pSC080, the same gene fragment was
PCR-ampliﬁed using primers 50-TATAggatccAATGTCTTC-
CGCCAAAAGCG-30 and 50-TATAggtaccAATGATGACG-
ACCCCTATCGC-30 and cloned into vector pT25 (Karimova
et al., 1998) using BamHI and KpnI restriction sites (again
shown in lower case). Bacterial two-hybrid analyses were
performed following established protocols (Karimova et al.,
1998, 2000). E. coli BTH101 was transformed with pSC072 (or
pUT18 control) and pSC080 (or pT25 control) and the colour
of the resulting transformants was scored on MacConkey
media with 0.2% maltose (with a positive result being red).
For quantitative measurement of the interaction,  -galacto-
sidase assays were performed as described by Murdoch et al.
(2011) on double-transformed BTH101 grown at 303 K in
Luria–Bertani broth (LB) and permeabilized with toluene.
Replicate assays were performed on independent transfor-
mants.
2.4. Cellular localization of Lip
Wild-type S. marcescens strain Db10 and the lip mutant
SJC10 (Murdoch et al., 2011) were grown for 8 h at 303 K
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Table 1
Crystallographic statistics.
Values in parentheses are for the highest resolution shell.
Data set I Data set II
Space group C2 C2
Wavelength (A ˚ ) 1.5418 1.007
Unit-cell parameters (A ˚ ,  ) a = 139.7, b = 77.6,
c = 54.3,   = 98.4
a = 139.7, b = 77.8,
c = 54.5,   = 98.3
Resolution (A ˚ ) 19.7–2.35 (2.48–2.35) 39.8–1.92 (2.02–1.92)
No. of reﬂections recorded 94650 (11192) 280802 (38597)
Unique reﬂections 23495 (3109) 43478 (6188)
Completeness (%) 98.3 (90.0) 98.2 (95.8)
Multiplicity 4.0 (3.6) 6.5 (6.2)
hI/ (I)i 30.9 (6.6) 20.6 (3.7)
Anomalous completeness
(%)
95.7 (84.5) —
Anomalous multiplicity 2.0 (1.8) —
Wilson B (A ˚ 2) 47.7 32.7
No. of residues/waters — 541/336
Rmerge† (%) 2.6 (17.1) 4.9 (44.2)
Rwork‡ (%) — 22.0
Rfree§ (%) — 29.2
Average B factors (A ˚ 2)
Chain A — 36.1
Chain B — 41.6
Chain C — 49.5
Chain D — 59.8
Waters — 46.2
Na
+ — 37.8
Ethylene glycol — 60.2
Cruickshank DPI} (A ˚ ) — 0.2
Ramachandran plot
Most favoured — 516 residues
Additional allowed — 21 residues
Outliers — Molecule D: Phe97,
Asp129; molecule B:
Pro142, Ser154
R.m.s.d. on ideal values††
Bond lengths (A ˚ ) — 0.01
Bond angles ( ) — 1.42
† Rmerge =
P
hkl
P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the intensity of
the ith measurement of reﬂection hkl and hI(hkl)i is the mean value of Ii(hkl) for all i
measurements. ‡ Rwork =
P
hkl
   jFobsj j Fcalcj
   =
P
hkl jFobsj, where Fobs is the observed
structure factor and Fcalc is the calculated structure factor. § Rfree is the same as Rcryst
except calculated with a subset (5%) of data that were excluded from the reﬁnement
calculations. } Cruickshank (1999). †† Engh & Huber (1991).in LB. Subcellular fractionation was performed following
an established method (Hatzixanthis et al., 2003). In brief,
following isolation of clean supernatant by centrifugation,
washed cell pellets were resuspended in 50 mM Tris–HCl pH
7.5, 40%(w/v) sucrose at 10 ml per gram of cells. EDTA was
then added to 5 mM (ﬁnal concentration) and lysozyme was
added to 0.6 mg ml
 1 before incubation at 310 K for 30 min.
Sphaeroplasts were harvested by centrifugation and taken up
in an equivalent volume of 50 mM Tris–HCl pH 7.5 before
French pressure treatment. Following ultracentrifugation of
the resultant crude extract, the isolated membranes were
again taken up in an equivalent volume of 50 mM Tris–HCl
pH 7.5. This protocol ensured that equivalent proportions of
each cell fraction were assayed. 4 ml of each fraction was
mixed with SDS sample buffer (100 mM Tris–HCl pH 6.8,
3.2% SDS, 3.2 mM EDTA, 16% glycerol, 0.2 mg ml
 1
Bromophenol blue, 2.5%  -mercaptoethanol) and separated
by 15% SDS–PAGE prior to anti-Lip immunoblotting. Whole-
cell samples comparing wild-type versus SJC10 were prepared
by resuspending cells from 100 ml culture in 100 ml SDS
sample buffer and boiling for 5 min prior to loading 6 ml onto
the gel. Following SDS–PAGE, proteins were electroblotted
onto polyvinylidine ﬂuoride membrane (Millipore). SmLip
was detected by hybridization of the primary antibody poly-
clonal rabbit anti-Lip (1:4000) followed by the secondary
antibody HRP-conjugated goat anti-rabbit (Thermo; 1:10000)
and the use of an enhanced chemiluminescent detection kit
(Millipore).
3. Results and discussion
3.1. Structure determination
Full-length SmLip consists of 176 residues. A truncated
version of SmLip consisting of an N-terminal hexahistidine
tag plus a TEV protease recognition site followed by residues
Ala30–Asp176 was obtained in recombinant form and puri-
ﬁed. The N-terminal 29 amino acids, which include the lipid-
ation signal peptide and the ﬁrst four residues of the mature
protein, have been omitted. This sample gave monoclinic
crystals. The asymmetric unit consists of four polypeptide
chains, labelled A–D, with an estimated solvent content of
45% and a VM of 2.27 A ˚ 3 Da
 1.
Medium-resolution diffraction data were recorded in-house
and the anomalous scattering information was used in a SAD
approach to phasing. 13 potential iodide positions were
identiﬁed and produced a ﬁgure of merit of 0.43 to 2.35 A ˚
resolution. Subsequently, 12 of these positions were conﬁrmed
by reﬁnement with this data set. The initial model constructed
in RESOLVE consisted of 293 residues, with a correlation
coefﬁcient of 0.55 and Rwork and Rfree values of 46% and 49%,
respectively. The ﬁrst round of model building in Coot
extended this to 467 residues, with a correlation coefﬁcient of
0.72 and Rwork and Rfree values of 33% and 37%, respectively.
At this point the high-resolution synchrotron data (1.92 A ˚
resolution) became available and were used to continue the
analysis. The reﬁnement proceeded with the release of NCS
restraints and the incorporation of water molecules, an Na
+
ion, ethylene glycol and a number of side chains with dual
rotamer conformations. This data set was derived from crystals
grown in the presence of chloride instead of iodide. However,
we did not assign any chloride ions to the structure, noting that
typical water molecules occupy the previously identiﬁed
iodide-binding sites. The reﬁnement was terminated when
there were no signiﬁcant changes in Rwork and Rfree and
inspection of the difference density map suggested that no
further corrections or additions were justiﬁed. Several dual
rotamers are incorporated into the model. Disorder was
evident at several positions, for example the N-terminus,
where it was not possible to interpret diffuse and weak elec-
tron density. Consequently, several residues are absent from
the model. Molecule A consists of residues 32–173; molecule B
of residues 33–142 and 147–176; molecule C of residues 34–50,
53–143 and 147–175; and molecule D of residues 33–50 and
55–175. The geometry of the model is acceptable (Table 1).
3.2. Self-association and localization in vivo
Previous work on SciN, the Lip homologue from entero-
aggregative E. coli, showed that the protein is localized in the
outer membrane, facing the periplasm (Aschtgen et al., 2008).
Examination of the amino-acid sequence of the N-terminus of
SmLip predicts that this is also an outer-membrane lipopro-
tein. The LipoP 1.0 algorithm (Juncker et al., 2003) predicts
that SmLip has a lipoprotein signal peptide and that signal
peptidase II cleavage occurs between Gly25 and Cys26, with
the cysteine subsequently being lipidated. Additionally, the
residue at the +2 position following cleavage is Met27 (i.e.
it is not an aspartate, which directs retention in the inner
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Figure 1
Detection of Lip–Lip self-interaction. The bacterial two-hybrid system
was used to detect an in vivo interaction between Lip (minus signal
peptide) fused to T25 (pSC080) and Lip (minus signal peptide) fused to
T18 (pSC072). The empty vectors pUT18 and pT25 represent negative
controls. The graph shows the output from the two-hybrid system
detected as  -galactosidase activity expressed relative to the pUT18/pT25
baseline level (the maximal  -galactosidase activity observed for the Lip–
Lip interaction corresponded to >5000 Miller units). Bars show mean  
SEM. Inset: colourimetric readout of the two-hybrid assay following
growth of E. coli BTH101 carrying the above plasmids on MacConkey–
maltose agar (red is a positive result).membrane); therefore, SmLip should proceed to the outer
membrane via the Lol system (Bos et al., 2007).
In order to investigate whether SmLip undergoes self-
interaction, the bacterial two-hybrid system (Karimova et al.,
2000) was utilized in E. coli. This assay involves reconstitution
of adenylate cyclase activity from two non-interacting cyclase
fragments, called T18 and T25, from Bordetella pertussis.T h e
presence of cyclic AMP activates the transcription of maltose
and lactose catabolic operons by E. coli. This can be detected
by direct measurement of  -galactosidase activity or by using
the observation that bacteria capable of fermenting maltose
acidify the medium and thus generate a red colour on
MacConkey–maltose indicator plates.
SmLip was introduced as both bait and prey by encoding
on plasmids pUT18 and pT25, and a strong positive result
was observed (Fig. 1). Mature SmLip (lacking the N-terminal
signal peptide) was used for this experiment, ﬁrstly to corre-
spond to the form of SmLip for which the structure was
solved and secondly to ensure that both partners were local-
ized together in the cytoplasm after fusion with T18 or T25.
This positive result indicates that Lip does indeed self-
associate within the cell and that neither localization in the
outer membrane nor other components of the type VI
secretion apparatus are required for self-interaction. We note,
however, that this system is unable to distinguish between
dimerization or higher order oligomerization.
As a control for any propensity of SmLip to form non-
speciﬁc interactions, in addition to the lack of interaction with
the T18 and T25 proteins demonstrated in Fig. 1 we tested
whether SmLip gave a positive bacterial two-hybrid result
with several cytoplasmic components of the T6SS (with which,
as a periplasmic protein, it should not interact). SmLip gave a
negative result (indistinguishable from the T25 + T18 negative
control) when tested against the proteins VipB, TssK and TssL
(data not shown).
In order to conﬁrm the localization of the native Lip protein
in S. marcescens, we utilized an anti-Lip polyclonal antibody
to probe each of the major cellular fractions in this organism.
As shown in Fig. 2, native SmLip is found exclusively in the
membrane fraction, conﬁrming the predicted localization of
the protein and the functionality of the signal peptide.
3.3. Overall structure
The SmLip polypeptide can be classiﬁed as a new member
of the transthyretin-like superfamily and a detailed compar-
ison will be given below. The protein displays a compact
globular structure dominated by an eight-stranded  -sandwich
(Fig. 3; Supplementary Fig. S1
1). The order of the strands is
8–7–1–4 and 6–5–2–3. There are three short  -helical segments
and three 310-helix turns. The four SmLip polypeptide chains
in the asymmetric unit are similar, with the root-mean-square
(r.m.s.) deviations between superimposed C
  atoms ranging
from 1.3 A ˚ (monomers A and B) to 0.8 A ˚ (monomers A and
D) with an average value of 0.95 A ˚ .
Although a set of core conserved proteins are encoded by
the T6SS gene clusters in different Gram-negative bacteria
(data not shown), there is a large degree of variation in the
amino-acid sequences of these proteins. Lip and its ortho-
logues, for example, are relatively poorly conserved.
Excluding the signal peptide and lipobox motif (Fig. 4), SmLip
shares only about 20% sequence identity with SciN, the
homologue from enteroaggregative E. coli. This increases to
near 40% in comparison with the homologue from the
P. aeruginosa HSI-1 T6SS. Sequence conservation is noted in
loop 1, near  1 and  2, in loop 2 and in the loop 4– 6 region
(Fig. 4).
An alignment of SmLip with eight orthologues (Supple-
mentary Fig. S2
1) reinforces the observation of a low level
of sequence identity for this protein. Excluding two residues
research papers
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Figure 2
Cellular localization of native SmLip in S. marcescens. Anti-Lip
immunoblot of whole cells or cellular fractions prepared from wild-type
S. marcescens strain Db10 or the lip mutant SJC10 (WC, whole cell;
Peri, periplasm; Sph, sphaeroplast; Cyto, cytoplasm; Memb, membranes).
The predicted size of mature SmLip is 16 kDa.
Figure 3
The secondary structure and fold of SmLip.  -Strands are shown as blue
arrows and  -helices and 310-turns as red and green ribbons, respectively.
The N- and C-terminal residues are labelled and the orientation of the
protein with respect to the outer membrane and periplasm is suggested.
1 Supplementary material has been deposited in the IUCr electronic archive
(Reference: MN5005). Services for accessing this material are described at the
back of the journal.in the lipobox motif, only six residues are strictly conserved:
Asn48, Leu99-X-Pro101-Gly102, Gly120 and Ala124. All six
residues appear to contribute to the conformation of speciﬁc
parts of the fold (data not shown). The side chain of Asn48
accepts a hydrogen bond from the main-chain amide of
Gln126, helping to deﬁne the conformation of loop 4. The
Leu99-X-Pro101-Gly102 segment deﬁnes the structure of the
turn after  3 leading into loop 2. Gly120 and Ala124 occur in
 5 and contribute hydrogen bonds to form interactions with
 2a n d 6 on either side. An increase in size of the side chain
at either of these positions would be likely to be disruptive to
the formation of this  -sheet, which forms one side of the
structure. There is no obvious hydrophobic, basic or acidic
surface feature on SmLip that is likely to be conserved within
the Lip proteins since the few conserved residues are mainly
buried.
The information provided in x3.2 identiﬁes that the
N-terminus of the structure is placed close to the outer
membrane, hence the assignment of the orientation of SmLip
with respect to the outer membrane (Fig. 3). By extension, we
note that the areas of SmLip in which sequence conservation
is observed mainly appear to contribute to stabilizing parts
of the structure that jut out into the periplasm. They may
therefore serve to deﬁne the structure of parts of Lip that are
responsible for interaction with other
molecules in the periplasm.
3.4. The tetramer is likely to be a
crystallographic artefact
Gel-ﬁltration data acquired during
puriﬁcation indicated that SmLip is a
monomer in solution (data not shown).
In contrast, the bacterial two-hybrid
data revealed a propensity for self-
interaction and the asymmetric unit is
a tetramer displaying 222 point-group
symmetry (Fig. 5). The accessible
surface area (ASA) of the SmLip poly-
peptide averages out at approximately
8350 A ˚ 2; the range is from 8200 A ˚ 2 for
molecule D to 8510 A ˚ 2 for molecule A.
Each molecule in the asymmetric unit
interacts with two of the other three and
two types of protein–protein interface
are formed between molecules A–B and
C–D (interface I) and between mole-
cules A–C and B–D (interface II). The
type I interface, which is larger, covers
an area that is approximately 13% of
the ASA of the SmLip molecule. Such
coverage certainly indicates potential
for a biologically relevant dimer. This
interface is primarily formed by the
antiparallel alignment of two  7 strands.
Three aromatic residues, Phe147,
Trp151 and Phe153, contribute van der
Waals interactions to the association and, by virtue of their
relative bulk, also to the ASA (data not shown). The type II
interface covers about 6.5% of the ASA of a molecule, a level
typical of the values observed simply owing to molecular
packing in a crystal lattice. This interface is formed by the
antiparallel alignment of two  4 strands. The areas of SmLip
involved in forming a tetramer are not conserved in the
homologues from E. coli or P. aeruginosa (Fig. 4) and it is
unlikely that such a tetramer is a generic feature of this
lipoprotein.
The spatial placement of the N-terminal residues in the
asymmetric unit is such that it is unlikely that an oligomeric
assembly could form when the protein is anchored in the
membrane by the lipidated Cys26 at the N-terminus. The
N-termini of molecules A and D are on the same side of the
tetrameric assembly but are opposite to those of molecules B
and C. As explained, there are no direct interactions formed
between molecules A and D or molecules B and C. That the
bacterial two-hybrid experiments reveal a propensity for self-
interaction of the truncated protein in the cytoplasm is in one
sense consistent with the crystal structure of the truncated
version of SmLip, which shows a tetrameric assembly con-
taining a plausible dimer. On the other hand, the structure
of the tetramer is incompatible with dimeric or tetrameric
research papers
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Figure 4
The primary and secondary structure of SmLip and sequence alignment with two homologues.
S. marcescens Lip is aligned with the homologous proteins from enteroaggregative E. coli
(GenBank CBG37366.1) and P. aeruginosa (NCBI Reference Sequence NP_248770.1, PA0080).
The secondary structure of SmLip is depicted with blue arrows for  -strands and red and green
cylinders for  -helices and 310-helices, respectively. Residues conserved in all three sequences are
shown in black boxes and those conserved in only two sequences are shown in grey boxes. The start
and ﬁnish of the lipobox motif are marked by red boxes; the residues at the start and end of the
sequence used in thestructure analysis (Ala30–Asp176) are shown in blue boxes.The alignment was
generated using T-Coffee (Di Tommaso et al., 2011) in the M-Coffee mode and the ﬁgure was
prepared using ALINE (Bond & Schu ¨ttelkopf, 2009).structures if the N-terminus is membrane-bound. These
observations may be a result of the different concentrations
and experimental conditions used. We suggest that SmLip is
a membrane-bound monomer but displays a propensity to
interact with itself.
A reviewer commented on the possibility that the SmLip
tetramer might represent an inactive or alternative state of the
protein. This is an intriguing suggestion and raises questions
about how conversion to an active form might occur and how
the T6SS itself is regulated. We have no data to address this
issue and further studies would be required to investigate such
a possibility.
3.5. Comparisons with structural homologues
A search for structural neighbours in the Protein Data
Bank using the PDBeFold (http://pdbe.org/fold) and ProFunc
servers (Laskowski et al., 2005) gives a Z score of 6.1 with sea
bream transthyretin (Eneqvist et al., 2004; PDB entry 1sn0).
This matched 84 residues with an r.m.s.d. of 2.7 A ˚ .T h e -sheet
structures align well (Supplementary Fig. S3). The r.m.s.d. and
relatively low Z score reﬂect the low sequence identity shared
between the two proteins of approximately 7%. Nevertheless,
the structural relationship is clear and SmLip can be classed as
a new member of the transthyretin-like protein family. The
only other member of this protein family is 5-hydroxyisourate
hydrolase (EC 3.5.2.17; Hennebry et al., 2006), an enzyme that
is found onlyin prokaryotes, leading to the conclusion that this
represents an example of divergent evolution (Hennebry,
2009). The sequence identity shared between this hydrolase
and SmLip is only 6%, but the similarity in fold is evident
(data not shown). We carried out further comparisons seeking
to inform on Lip function.
Transthyretin binds the hormone thyroxine, self-interacts to
form a tetramer and also forms a complex with retinol-binding
protein (Blake et al., 1978; Wojtczak et al., 1992; Monaco et
al., 1995; Zanotti et al., 2008). In common with transthyretin,
SmLip forms a tetrameric assembly. However, the SmLip
oligomer is distinct and an overlay of one SmLip polypeptide
with a subunit from transthyretin does not produce an overlap
of any of the other polypeptides (data not shown).
Transthyretin forms a dimer by antiparallel self-association
of the  6 and  8 strands, creating a curved eight-stranded
 -sheet (Blake et al., 1978). The binding of the hormone
thyroxine occurs at the tetramer interface created by the
convex surfaces of two of these eight-stranded  -sheets as the
protein assembles as a dimer of dimers. The thyroxine-binding
residues in transthyretin are not conserved in SmLip and an
overlay of an SmLip polypeptide and transthyretin subunit
places the ligand-binding site on the surface of the former
(Supplementary Fig. S3). It is unlikely that SmLip acts to bind
hydrophobic ligands of the type that transthyretin can bind.
Transthyretin associates with retinol-binding protein using
residues in three turns: two from one subunit that link  1t o
 2 and  4t o 5, and one from another subunit that links  1
to  2 (Monaco et al., 1995). These parts of the transthyretin
structure correspond to loops 1 and 3 of SmLip. Loop 1 is
directed out from the globular fold into the periplasmic space;
it is placed to interact with physiological partners and may
represent a binding site for other proteins/molecules.
In a recent study of Klebsiella pneumoniae 5-hydroxy-
isourate hydrolase, the residues important for catalytic func-
tion were conﬁrmed as His7, Arg41, His92 and Ser108, which
together with Tyr105 form a polar and symmetric active site at
a dimer interface (French & Ealick, 2011). A structure-based
sequence alignment matches four of these catalytic residues
(with the exception being Ser108) to Asp42, Gly105, His161
and Val172, respectively, in SmLip. The polypeptides do not
overlay in the vicinity of Ser108 (data not shown) and it is
unlikely that Lip has any hydrolase activity.
The biological role of SmLip or its orthologues in the T6SS
has yet to be unambiguously deﬁned. Structural comparisons
appear to rule out, rather than assign, a function. The pro-
pensity to self-associate using parts of the SmLip structure
that will be exposed in the periplasm suggests that this protein,
exploiting the lipid anchor, helps to bind and position different
components of the secretion apparatus at the outer mem-
brane. Future experiments, aided by the structural model, can
address this hypothesis.
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